-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The incidence of eosinophilic esophagitis (EoE) is increasing in children and adults
.
It is characterized by the clinical and histological consequences of chronic Th2 immune- mediated inflammation and the resulting esophageal dysfunction
The incidence of eosinophilic esophagitis (EoE) is increasing in children and adults
The researchers collected esophageal biopsy samples from EoE and healthy people, and isolated and cultured primary human esophageal epithelial cells for PAI-1 immunohistochemistry and cell proliferation experiments
.
PAI-1 immunostaining and basal cell hyperplasia were evaluated in the context of endoscopic imaging probe (EndoFLIP) esophageal compliance measurement
The results of the study showed that 45 children (32 with EoE and 13 without EoE) were measured with EndoFLIPs and found that compared with inactive or control patients, the epithelial PAI-1 of patients with active EoE was significantly increased (P< .
01 p eoe ci pai-1>
This study confirmed that PAI-1 is significantly elevated in children with EoE and can be used to distinguish changes in children's esophageal compliance
.
Therefore, PAI-1 may be a new disease marker and therapeutic target
Original source:
Prerana Williamson.
Et al.
Plasminogen Activator Inhibitor-1 as a Marker of Esophageal Functional Changes in Pediatric Eosinophilic Esophagitis.
Clinical Gastroenterology and Hepatology.
2021 .
01 p eoe ci pai-1>
This study confirmed that PAI-1 is significantly elevated in children with EoE and can be used to distinguish changes in children's esophageal compliance
.
Therefore, PAI-1 may be a new disease marker and therapeutic target
Original source:
Prerana Williamson.
Et al.
Plasminogen Activator Inhibitor-1 as a Marker of Esophageal Functional Changes in Pediatric Eosinophilic Esophagitis.
Clinical Gastroenterology and Hepatology.
2021 .
This study confirmed that PAI-1 is significantly elevated in children with EoE and can be used to distinguish changes in children's esophageal compliance
.
Therefore, PAI-1 may be a new disease marker and therapeutic target
This study confirmed that PAI-1 is significantly elevated in children with EoE and can be used to distinguish changes in children's esophageal compliance
Prerana Williamson.
Plasminogen Activator Inhibitor-1 as a Marker of Esophageal Functional Changes in Pediatric Eosinophilic Esophagitis.
Leave a message here